Delivery Order SPE2DB22D3401-SPE2DB24FT4UM

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,070.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567130613 - Lidocaine 2% Viscous Solution 100ML, a medical product used in various healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 4, 2025. It is not designated as a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Lidocaine 2% Viscous Solution 100ML, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed-price arrangement with a ceiling value of $1,037.48 and a performance period through March 11, 2024. Amerisourcebergen Drug...
This federal contract award, valued at $2,419.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of November 17, 2023, and is a Firm Fixed Price Delivery Order. The award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,123.68, is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $8,737.98 to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,564,298,127 units of Lidocaine 2% Viscous Solution in 100 mL containers. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Amerisourcebergen, a subsidiary of the pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,501.89 firm fixed price delivery order is for the supply of 4564380686 - Lidocaine 2% Viscous Solution in 100 ML containers. This contract has no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,692.34, is for the delivery of 100ML bottles of 2% lidocaine viscous solution. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of January 22, 2025 and was awarded on January 21, 2025. This contract is not designated as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order valued at $1,584.01 for the supply of Lidocaine 2% Viscous Solution, 100 ML. The award has a completion date of February 5, 2024 and was made on February 2, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $2,823.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lidocaine 2% Viscous Solution in 100ml containers, a medical product used for various healthcare applications. The contract is a firm fixed-price delivery order with a period of performance through March 2024. This award is part of Amerisourcebergen's broader...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4UM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $50,251.30, is for the delivery of Lidocaine 2% Viscous Solution, a medical product, to support various government agencies and healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp has been awarded numerous contracts by the DLA and other federal agencies to supply a wide range of pharmaceutical and medical supplies, including specialty medications, vaccines, and medical equipment, to military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000, respectively, for delivering a comprehensive range of medical commodities to support government healthcare needs.

Generated 12/19/24, 9:04 AM